leo 27847
Small moleculeexperimental
Clinical trial activity
4 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2009 (NCT01007383)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- leo 27847
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01143298 | Phase 1 | Jun 1, 2010 | Covance, Leo Pharma |
| NCT01167309 | Phase 1 | Jun 1, 2010 | CRS Clinical Research Services Kiel GmbH, Leo Pharma |
| NCT01141179 | Phase 1 | May 1, 2010 | Leo Pharma, SFBC Anapharm |
| NCT01007383 | Phase 1 | Sep 1, 2009 | Covance, Leo Pharma |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Leo Pharma | For profit | 4 | 4 | 1 | 2009 |
| Covance | For profit | 2 | 0 | 1 | 2009 |
| CRS Clinical Research Services Kiel GmbH | For profit | 1 | 0 | 1 | 2010 |
| SFBC Anapharm | For profit | 1 | 0 | 1 | 2010 |
4 organizations
Page 1 / 1